Novo Nordisk's weight loss pill is expanding the obesity treatment market as an alternative to injectable GLP-1 medications. CNBC spoke with patients about their experience on the pill and explains how the drug is facing competition from Eli Lilly's oral weight loss pill. Watch the video to learn mo...